Covovax nod to strengthen immunization efforts in India: SII Roshni Dhar31 Dec 2021 10:30 AM ISTVaccine major serum institute of India (SII) on Tuesday said the approval for the covid-19 vaccine 'covovax' would strength immunization across India...
Biological E bags DCGI nod for Corbevax trials as booster dose Ruchika Sharma30 Dec 2021 12:39 PM ISTNew Delhi: The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3...
Covovax better booster for Covishield-vaccinated people, says Shahid Jameel Ruchika Sharma30 Dec 2021 9:15 AM ISTNew Delhi: Of the vaccines against COVID-19 approved in India, Covovax would be a better booster for those who were administered Covishield jabs than...
Immunization efforts in India, lower, middle income countries to strengthen with Covovax approval, says SII Ruchika Sharma29 Dec 2021 2:14 PM ISTCovovax is produced by Pune-based SII under licence from Novavax.
Biological E plans to make 100 million Corbevax doses per month from February Ruchika Sharma29 Dec 2021 1:15 PM ISTNew Delhi: Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating...
Anti-COVID pill Molnupiravir, Covovax, Corbevax get CDSCO panel emergency use nod Ruchika Sharma28 Dec 2021 11:19 AM ISTAll the recommendations have been sent to the Drug Controller General of India (DCGI) for final approval.
CoronaVac third dose ineffective against Omicron, says study contrary to Sinovac claim Dr Pooja27 Dec 2021 2:51 PM ISTHong Kong: China's Sinovac Covid-19 vaccine (CoronaVac) doesn't provide sufficient antibodies to fend off Omicron, a study by two Hong Kong...
DCGI approves Covaxin for children above 12 years Medical Dialogues Bureau27 Dec 2021 12:09 PM ISTNew Delhi : The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin...
CanSino Biologics COVID vaccine shows 57.5 percent efficacy in Phase 3 study Ruchika Sharma26 Dec 2021 9:15 AM ISTBeijing: CanSino Biologics Inc's vaccine was 57.5% effective against symptomatic COVID-19 and 91.7% against severe disease four weeks or longer after...
Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months Ruchika Sharma25 Dec 2021 3:40 PM ISTNew Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...
Covishield protection diminishes after 3 months, says Lancet study Roshni Dhar25 Dec 2021 12:18 PM ISTThe protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to...
Serum Institute waives indemnity over AstraZeneca COVID vaccine for refugees Ruchika Sharma24 Dec 2021 9:00 AM ISTNew Delhi: The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies...
